🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the cognitive enhancing effect of BF2.649 and to evaluate the e...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2008-06
Trial ID
NCT00690274
The primary objective of this study is to determine the safety, tolerabilit...
Status
Terminated
Location
High Point Clinical Trials Center
Start Date
2019-09-15
Trial ID
NCT04026750
Treatments Being Tested
This is a multicentric International Phase III,Long term open label study(1...
Status
Completed
Location
CHU Montpellier
Start Date
2011-05
Trial ID
NCT01399606
Treatments Being Tested
This EAP will be open to provide access to treatment with pitolisant while ...
Status
No Longer Available
Location
Sleep Disorders Center of Alabama
Start Date
TBD
Trial ID
NCT03433131
Treatments Being Tested
The purpose of this study is to assess safety of pitolisant in eligible par...
Status
Enrolling By Invitation
Location
Science 37
Start Date
2025-08-20
Trial ID
NCT07219485
Treatments Being Tested
The first objective of this study is to demonstrate the efficacy and safety...
Status
Withdrawn
Location
Laboratoire du sommeil Clinique de Physiologie, Sommeil et Exercice Pôle Thorax et Vaisseaux CHU de Grenoble
Start Date
TBD
Trial ID
NCT02978651
Treatments Being Tested
The objective of this trial is to define the minimum effective dose of BF 2...
Status
Completed
Location
Pitié-Salpêtrière Hospital
Start Date
2007-10
Trial ID
NCT00642928
Treatments Being Tested
Multicenter randomized double blind study versus placebo during 12 weeks wi...
Status
Completed
Location
CHU Grenoble
Start Date
2011-08
Trial ID
NCT01071876
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
UCI Center for Clinical Research
Start Date
2021-06-28
Trial ID
NCT04886518
Treatments Being Tested